Skip to main content
editorial
. 2020 Apr 27;50(1):43–53. doi: 10.1007/s11239-020-02120-9

Fig. 1.

Fig. 1

Targeted approach to drug development for SARS-CoV-2. The lines of attack against SARS-CoV-2, numbered 1–6, include inhibition of: (1) fusion; (2) translation; (3) proteolysis; (4) translation and RNA replication; (5) packaging and; (6) virion release. From Kupferschmidt and Cohen [3]. With permission

HHS Vulnerability Disclosure